16 October 2023: Viona launches Acetazolamide Tablets, USP 125 mg and 250 mg
31 July 2023: Viona launches Febuxostat Tablets, 40 mg and 80 mg
31 July 2023: Viona launches Sucralfate Tablets, USP 1 gram
We’re setting a new standard for high-quality, low-cost generics.
Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider.
Learn More About UsAcetazolamide Tablets, USP
COMPARED TO: Diamox®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Carbonic anhydrase inhibitors
Sucralfate Tablets, USP
COMPARED TO: Carafate®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Antiulcer
Metronidazole Topical Cream
COMPARED TO: Metrocream®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Anti-inflammatory
PRODUCTS
Viona is currently marketing a range of Oral Solids and Topical products. We have a vast number of generic pharmaceutical products in the pipeline, which we are excited to introduce to the market soon.
Explore our Products
16 October 2023: Viona launches Acetazolamide Tablets, USP 125 mg and 250 mg
31 July 2023: Viona launches Febuxostat Tablets, 40 mg and 80 mg
31 July 2023: Viona launches Sucralfate Tablets, USP 1 gram